InvestorsHub Logo

jckrdu

10/23/19 11:58 AM

#47350 RE: chickpea598 #47348

Chickpea - See "Waitforit"'s post a ways down where he referenced a post I made on another board after asking DOC that exact question. The explanation I got was that - per Dan's interactions with Merck - Merck's business development team generally only pulls the trigger on deals (ie buyouts, taking equity stakes, etc) if they see other competitors actively interested and they're forced to act, if they want to continue to work with the company. ONCS is small potato's in the grand scheme of things, but this pending deal with CGP seems to align with Dan's prior comments, and maybe his thinking.

I'm not investing in ONCS assuming Merck is going to make a competing offer, but it certainly wouldn't surprise me.

trading.jeff

10/23/19 12:36 PM

#47357 RE: chickpea598 #47348

Peeps have been talking about a Merck buyout or licensing agreement for five years. If Merck was interested, they would have pulled the trigger. There must be something about OncoSec they don't like.

But, at the end of the day, we are all just armchair quarterbacks.

$ONCS